ED-Initiated School-based Asthma Medication Supervision

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

December 30, 2020

Study Completion Date

January 1, 2021

Conditions
AsthmaAsthma in Children
Interventions
DRUG

ED-Dispensing home and school supervision

"1. Oral prednisolone based on body weight to achieve a daily dose of 2mg/kg/day not to exceed 40 mg per day for 5 days or its equivalent (provided in the emergency department),~2. 360 ug of budesonide inhalation powder once-daily for at-home use, and~3. albuterol sulfate as needed for relief of acute respiratory symptoms."

Trial Locations (1)

85724

Asthma & Airway Disease Research Center, Tucson

All Listed Sponsors
lead

Ashley Lowe

OTHER

NCT03952286 - ED-Initiated School-based Asthma Medication Supervision | Biotech Hunter | Biotech Hunter